Marimed (MRMD) Current Assets (2011 - 2026)
Marimed's (MRMD) quarterly Current Assets came in at $60.8 million in Q1 2026, up 4.8% year-on-year from $58.0 million in Q1 2025, and up 2.53% on a QoQ basis from $59.3 million in Q4 2025.
Marimed (MRMD) Current Assets (2011 - 2026) Analysis & Trends
Marimed (MRMD) has 16 years of Current Assets data on file, last reported at $60.8 million in Q1 2026.
- On a quarterly basis, Current Assets rose 4.8% year-over-year to $60.8 million in Q1 2026; TTM through Mar 2026 was $60.8 million, a 4.8% increase from a year earlier, with the FY2025 full-year figure at $59.3 million, up 10.8% from the prior year.
- Current Assets for Q1 2026 stood at $60.8 million, up from $59.3 million in the prior quarter.
- Over the last five years, Current Assets for MRMD reached as high as $60.8 million in Q1 2026 and fell as low as $33.6 million in Q2 2022.
- Historically, Current Assets has averaged $53.3 million across 5 years, with a median of $54.9 million in 2024.
- Across the five-year window, Current Assets retreated 17.88% in 2022 and jumped 72.63% in 2023, its largest moves.
- Year by year, Current Assets stood at $44.1 million in 2022, then grew by 16.5% to $51.4 million in 2023, then grew by 4.04% to $53.5 million in 2024, then increased by 10.8% to $59.3 million in 2025, then gained by 2.53% to $60.8 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $60.8 million in Q1 2026, $59.3 million in Q4 2025, and $60.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 60.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.79 Mn |
| Dec 31, 2025 | 59.29 Mn |
| Sep 30, 2025 | 60.09 Mn |
| Jun 30, 2025 | 57.13 Mn |
| Mar 31, 2025 | 58.00 Mn |
| Dec 31, 2024 | 53.51 Mn |
| Sep 30, 2024 | 56.68 Mn |
| Jun 30, 2024 | 53.05 Mn |
| Mar 31, 2024 | 54.90 Mn |
| Dec 31, 2023 | 51.43 Mn |
| Sep 30, 2023 | 50.79 Mn |
| Jun 30, 2023 | 57.92 Mn |
| Mar 31, 2023 | 59.37 Mn |
| Dec 31, 2022 | 44.15 Mn |
| Sep 30, 2022 | 40.88 Mn |
| Jun 30, 2022 | 33.55 Mn |
| Mar 31, 2022 | 54.31 Mn |
| Dec 31, 2021 | 44.61 Mn |
| Sep 30, 2021 | 49.79 Mn |
| Jun 30, 2021 | 39.76 Mn |